23andMe revolutionizes personal genomics by empowering individuals with genetic insights into their health through accessible, at-home DNA testing. Its health reports reveal genetic risks for conditions like Type 2 diabetes, Alzheimer's, and certain cancers, helping people make informed decisions about their well-being. With over 15 million genotyped customers, 23andMe contributes to vital medical research, including breakthroughs in understanding diseases like Parkinson's and late-onset Alzheimer’s. The company prioritizes privacy and transparency, advocating for the individuals’ right to access their genetic information, ultimately shaping the future of personalized, preventive healthcare.